Imperial College London
π§πͺBelgium
- Country
- π§πͺBelgium
- Ownership
- Private
- Established
- 1907-07-08
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.imperial.ac.uk
Repeat Nasal Allergen Challenge
Phase 2
Completed
- Conditions
- First Posted Date
- 2006-02-13
- Last Posted Date
- 2023-09-14
- Lead Sponsor
- Imperial College London
- Target Recruit Count
- 22
- Registration Number
- NCT00290368
- Locations
- π¬π§
National Heart & Lung Institute Clinical Studies Unit, London, United Kingdom
Isoflavones and the Coronary Circulation in Men and Women With Coronary Artery Disease
- First Posted Date
- 2006-02-07
- Last Posted Date
- 2019-08-05
- Lead Sponsor
- Imperial College London
- Target Recruit Count
- 71
- Registration Number
- NCT00287690
- Locations
- π¬π§
Royal Brompton & Harefield NHS Trust, London, United Kingdom
Cell Repair in Heart Failure
Phase 1
Withdrawn
- Conditions
- First Posted Date
- 2006-02-02
- Last Posted Date
- 2015-03-31
- Lead Sponsor
- Imperial College London
- Registration Number
- NCT00285454
- Locations
- π¬π§
The Department of Gene Therapy, The National Heart and Lung Institute, Imperial College London and The Royal Brompton Hospital., London, Middlesex, United Kingdom
TNF-alpha Directed Therapy in Asthma
Phase 2
Completed
- Conditions
- First Posted Date
- 2006-01-18
- Last Posted Date
- 2023-09-14
- Lead Sponsor
- Imperial College London
- Target Recruit Count
- 40
- Registration Number
- NCT00278083
- Locations
- π¬π§
NHLI Clinical Studies Unit, London, United Kingdom
Zidovudine Plus Lamivudine in HTLV-I-associated Myelopathy: a Randomised Trial
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2006-01-06
- Last Posted Date
- 2021-08-25
- Lead Sponsor
- Imperial College London
- Target Recruit Count
- 16
- Registration Number
- NCT00272480
- Locations
- π¬π§
Imperial College, London, United Kingdom
Enhancement of in-Vitro GC Function in Patients With COPD
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2005-10-19
- Last Posted Date
- 2019-12-04
- Lead Sponsor
- Imperial College London
- Target Recruit Count
- 49
- Registration Number
- NCT00241631
- Locations
- π¬π§
Windsor chest clinic KEVII Hospital, Windsor, Berks, United Kingdom
Testosterone and Myocardial Perfusion in Coronary Heart Disease (CHD)
- First Posted Date
- 2005-10-17
- Last Posted Date
- 2019-09-25
- Lead Sponsor
- Imperial College London
- Target Recruit Count
- 28
- Registration Number
- NCT00239590
- Locations
- π¬π§
Royal Brompton & Harefield NHS Trust, London, United Kingdom
Investigation of Coagulation Parameters in Hereditary Haemorrhagic Telangiectasia
Completed
- Conditions
- Interventions
- First Posted Date
- 2005-10-03
- Last Posted Date
- 2023-09-28
- Lead Sponsor
- Imperial College London
- Target Recruit Count
- 100
- Registration Number
- NCT00230659
- Locations
- π¬π§
Imperial College Hammersmith Campus, London, United Kingdom
Studies of White Blood Cells Derived From HHT Patients
Active, not recruiting
- Conditions
- First Posted Date
- 2005-10-03
- Last Posted Date
- 2023-09-28
- Lead Sponsor
- Imperial College London
- Target Recruit Count
- 200
- Registration Number
- NCT00230633
- Locations
- π¬π§
Imperial College Hammersmith Campus, London, United Kingdom
Case Notes Review on Patients With Hereditary Haemorrhagic Telangiectasia
Recruiting
- Conditions
- First Posted Date
- 2005-10-03
- Last Posted Date
- 2023-09-28
- Lead Sponsor
- Imperial College London
- Target Recruit Count
- 2000
- Registration Number
- NCT00230685
- Locations
- π¬π§
Respiratory Medicine, Hammersmith Hospital, London, United Kingdom
Β© Copyright 2024. All Rights Reserved by MedPath